![](https://www.optiknow.ca/wp-content/uploads/2019/01/Bausch-Lomb-810X338px.jpg)
Bausch + Lomb Announces Results from First Phase 3 Trial of NOV03
Thursday, April 15 2021 | 09 h 33 min | Dry Eye, News, Press Release
Bausch + Lomb and Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics, announced statistically significant...
Read More